FABHALTA
*Company:
Novartis Ireland LimitedStatus:
UpdatedLegal Category:
Supply through pharmacy onlyActive Ingredient(s):
This medicinal product is subject to additional monitoring.
*Additional information is available within the SPC or upon request to the company
File name
NOV1136_Fabhalta_RMP_PatientSafetyCard_Nov25_Final.pdf
Reasons for updating
- Add New Doc
File name
NOV1136_Fabhalta_RMP_PatientCaregiverGuide_Nov25_Final.pdf
Reasons for updating
- Add New Doc
File name
NOV1136_Fabhalta_RMP_HCP_Guide_Final.pdf
Reasons for updating
- Add New Doc
Free text change information supplied by the pharmaceutical company
HCP Guide
Updated on 27 November 2025
File name
Fabhalta_REG SPC_PF25-0040_200mg_April2025_clean_IPHA.pdf
Reasons for updating
- New SPC for new product
Legal category:Supply through pharmacy only
Updated on 27 November 2025
File name
Fabhalta_PF25-0040_REG PIL_April 2025_Clean_IPHA.pdf
Reasons for updating
- New PIL for new product
Novartis Ireland Limited
Address:
Vista Building, Elm Park Business Park, Merrion Road, Dublin 4, IrelandMedical Information E-mail:
medinfo.dublin@novartis.comTelephone:
+353 1 2601255Fax:
+353 1 2601263